THC-induced behavioral stereotypy in zebrafish as a model of psychosis-like behavior
Open Access
- 3 August 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-13
Abstract
High doses of the Cannabis constituent Δ9-tetrahydrocannabinol (THC) increase the risk of psychosis in humans. Highly accessible animal models are needed to address underlying mechanisms. Using zebrafish with a conserved endocannabinoid system, this study investigates the acute effects of THC on adult zebrafish behavior and the mechanisms involved. A concentration-dependent THC-induced behavioral stereotypy akin to THC’s effect in rats and the psychotropics phencyclidine and ketamine in zebrafish was established. Distinctive circular swimming during THC-exposure was measured using a novel analytical method that we developed, which detected an elevated Repetition Index (RI) compared to vehicle controls. This was reduced upon co-administration of N-methyl-D-aspartate (NMDA) receptor agonist NMDA, suggesting that THC exerts its effects via biochemical or neurobiological mechanisms associated with NMDA receptor antagonism. Co-treatment of γ‐aminobutyric acid receptor antagonist pentylenetetrazol also showed signs of reducing the RI. Since THC-induced repetitive behavior remained in co-administrations with cannabinoid receptor 1 inverse agonist AM251, the phenotype may be cannabinoid receptor 1-independent. Conversely, the inverse cannabinoid receptor 2 agonist AM630 significantly reduced THC-induced behavioral stereotypy, indicating cannabinoid receptor 2 as a possible mediator. A significant reduction of the THC-RI was also observed by the antipsychotic sulpiride. Together, these findings highlight this model’s potential for elucidating the mechanistic relationship between Cannabis and psychosis.Keywords
Funding Information
- National Institutes of Health (R01 DA035680)
This publication has 71 references indexed in Scilit:
- Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiologyProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2012
- Clozapine, but not haloperidol, enhances gliald‐serine and L‐glutamate release in rat frontal cortex and primary cultured astrocytesBritish Journal of Pharmacology, 2011
- Behavioral performance altering effects of MK-801 in zebrafish (Danio rerio)Behavioural Brain Research, 2011
- Behavioral effects of MDMA (‘ecstasy’) on adult zebrafishBehavioural Pharmacology, 2011
- Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)Drug and Alcohol Dependence, 2011
- Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in MiceNeuropsychopharmacology, 2011
- Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortexNeuroscience, 2010
- Modulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cellsBrain Research, 2010
- Executive Function, Neural Circuitry, and Genetic Mechanisms in SchizophreniaNeuropsychopharmacology, 2009
- Psychosocial Stress and Psychosis. A Review of the Neurobiological Mechanisms and the Evidence for Gene-Stress InteractionSchizophrenia Bulletin, 2008